Moleculin Biotech Statistics
Total Valuation
MBRX has a market cap or net worth of $8.59 million. The enterprise value is $1.62 million.
| Market Cap | 8.59M |
| Enterprise Value | 1.62M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MBRX has 973,869 shares outstanding. The number of shares has increased by 906.89% in one year.
| Current Share Class | 973,869 |
| Shares Outstanding | 973,869 |
| Shares Change (YoY) | +906.89% |
| Shares Change (QoQ) | +37.73% |
| Owned by Insiders (%) | 6.69% |
| Owned by Institutions (%) | 2.45% |
| Float | 838,699 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.27 |
| P/TBV Ratio | 19.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.94 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -671.51 |
Financial Efficiency
Return on equity (ROE) is -1,371.64% and return on invested capital (ROIC) is -703.03%.
| Return on Equity (ROE) | -1,371.64% |
| Return on Assets (ROA) | -84.57% |
| Return on Invested Capital (ROIC) | -703.03% |
| Return on Capital Employed (ROCE) | -245.24% |
| Weighted Average Cost of Capital (WACC) | 15.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.91M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.39% in the last 52 weeks. The beta is 2.00, so MBRX's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | -96.39% |
| 50-Day Moving Average | 10.92 |
| 200-Day Moving Average | 40.76 |
| Relative Strength Index (RSI) | 48.51 |
| Average Volume (20 Days) | 44,817 |
Short Selling Information
The latest short interest is 204,583, so 21.01% of the outstanding shares have been sold short.
| Short Interest | 204,583 |
| Short Previous Month | 287,608 |
| Short % of Shares Out | 21.01% |
| Short % of Float | 24.39% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.88M |
| Pretax Income | -30.33M |
| Net Income | -32.53M |
| EBITDA | -28.83M |
| EBIT | -28.88M |
| Earnings Per Share (EPS) | -$191.95 |
Balance Sheet
The company has $7.26 million in cash and $292,000 in debt, with a net cash position of $6.97 million or $7.16 per share.
| Cash & Cash Equivalents | 7.26M |
| Total Debt | 292,000 |
| Net Cash | 6.97M |
| Net Cash Per Share | $7.16 |
| Equity (Book Value) | 11.59M |
| Book Value Per Share | 32.64 |
| Working Capital | -590,000 |
Cash Flow
| Operating Cash Flow | -25.36M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 47,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.36M |
| FCF Per Share | -$26.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -906.89% |
| Shareholder Yield | -906.89% |
| Earnings Yield | -2,177.34% |
| FCF Yield | -297.74% |
Analyst Forecast
The average price target for MBRX is $240.00, which is 2,622.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $240.00 |
| Price Target Difference | 2,622.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |